Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of International Society of Preventive & Community Dentistry|August 28, 2015
Comparative evaluation of the antibacterial and physical properties of conventional glass ionomer cement containing chlorhexidine and antibioticsSudhir Mittal, Heena Soni, Devender Kumar Sharma, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy StudiesNan Zhang, Natasha Strydom, Sandeep Tyagi, et al.
Journal of Drug Targeting|October 21, 2010
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal routeSonal Patel, Sandip Chavhan, Heena Soni, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of TuberculosisSi-Yang Li, Rokeya Tasneen, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2025
The KasA inhibitor JSF-3285 improves the sterilizing activity of bedaquiline-pretomanid-containing regimens in a mouse model of tuberculosisHeena Soni, Sandeep Tyagi, Kishor Mane, et al.
The Journal of Infectious Diseases|January 30, 2020
Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of TuberculosisKristina M Bigelow, Amelia N Deitchman, Si-Yang Li, et al.
The Journal of Infectious Diseases|February 17, 2025
Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine ModelsBernard Ngara, Lorenzo Flori, Rob Christiaan van Wijk, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2024
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosisSi-Yang Li, Sandeep Tyagi, Heena Soni, et al.
Nature Communications|August 24, 2024
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimenNatasha Strydom, Jacqueline P Ernest, Marjorie Imperial, et al.
Plos One|May 3, 2018
A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosisStéphane Leung-Theung-Long, Charles-Antoine Coupet, Marie Gouanvic, et al.
Pageof 2